The Latin America, Middle East and Africa Transdermal Patches Market would witness market growth of 9.6% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 3,43,095.7 thousand units, showcasing a growth of 10.2% (2023-2030).
Nanotechnology is being explored to improve the efficiency of transdermal drug delivery. Nano-sized drug carriers can enhance skin penetration, allowing for increased drug absorption and potentially overcoming some of the challenges associated with large drug molecules. Nanoparticles, such as liposomes, micelles, and polymeric nanoparticles, can encapsulate drugs, protecting them from degradation and enhancing their penetration through the skin. These nanoparticles can be designed to release the drug in a controlled manner, improving therapeutic efficacy.
The exploration of biodegradable materials for patch construction is gaining momentum. Biodegradable patches offer environmental sustainability and may provide additional benefits regarding reduced skin irritation and enhanced patient comfort. Biodegradable materials can also offer advantages in terms of reduced skin irritation. Some traditional patch materials may cause irritation or allergic reactions in certain individuals due to their composition or adhesive properties.
The aging population in LAMEA is associated with a higher prevalence of chronic diseases such as cardiovascular conditions, diabetes, and arthritis. Transdermal patches offer a convenient and effective method of drug delivery for managing these chronic conditions, aligning with the healthcare needs of an aging demographic. Government initiatives and healthcare policies in some LAMEA countries may prioritize improving healthcare access for the aging population. Therefore, the increasing number of elder people in the LAMEA region will pose lucrative growth prospects for the market.
The Brazil market dominated the LAMEA Transdermal Patches Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $192.6 million by 2030. The Argentina market is showcasing a CAGR of 10.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 9.3% during (2023 - 2030).
Based on End User, the market is segmented into Homecare Settings and Hospitals & Clinics. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on Adhesive Type, the market is segmented into Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others. Based on Patch Type, the market is segmented into Drug-In-Adhesive, Matrix Patches, Reservoir Membrane Patches, Microneedle Patches, Iontophoresis Patches and Vapour Patches. Based on Application, the market is segmented into Pain Management, Smoking Cessation, Hormone Replacement Therapy, Cardiovascular Disorder, Central Nervous System Disorder and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Viatris, Inc. (Mylan N.V.), Boehringer Ingelheim International GmbH, Endo International PLC, Bayer AG, Nitto Denko Corporation, Cipla Limited, Amneal Pharmaceuticals, Inc., Novartis AG, and AbbVie, Inc.
Nanotechnology is being explored to improve the efficiency of transdermal drug delivery. Nano-sized drug carriers can enhance skin penetration, allowing for increased drug absorption and potentially overcoming some of the challenges associated with large drug molecules. Nanoparticles, such as liposomes, micelles, and polymeric nanoparticles, can encapsulate drugs, protecting them from degradation and enhancing their penetration through the skin. These nanoparticles can be designed to release the drug in a controlled manner, improving therapeutic efficacy.
The exploration of biodegradable materials for patch construction is gaining momentum. Biodegradable patches offer environmental sustainability and may provide additional benefits regarding reduced skin irritation and enhanced patient comfort. Biodegradable materials can also offer advantages in terms of reduced skin irritation. Some traditional patch materials may cause irritation or allergic reactions in certain individuals due to their composition or adhesive properties.
The aging population in LAMEA is associated with a higher prevalence of chronic diseases such as cardiovascular conditions, diabetes, and arthritis. Transdermal patches offer a convenient and effective method of drug delivery for managing these chronic conditions, aligning with the healthcare needs of an aging demographic. Government initiatives and healthcare policies in some LAMEA countries may prioritize improving healthcare access for the aging population. Therefore, the increasing number of elder people in the LAMEA region will pose lucrative growth prospects for the market.
The Brazil market dominated the LAMEA Transdermal Patches Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $192.6 million by 2030. The Argentina market is showcasing a CAGR of 10.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 9.3% during (2023 - 2030).
Based on End User, the market is segmented into Homecare Settings and Hospitals & Clinics. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on Adhesive Type, the market is segmented into Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others. Based on Patch Type, the market is segmented into Drug-In-Adhesive, Matrix Patches, Reservoir Membrane Patches, Microneedle Patches, Iontophoresis Patches and Vapour Patches. Based on Application, the market is segmented into Pain Management, Smoking Cessation, Hormone Replacement Therapy, Cardiovascular Disorder, Central Nervous System Disorder and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Viatris, Inc. (Mylan N.V.), Boehringer Ingelheim International GmbH, Endo International PLC, Bayer AG, Nitto Denko Corporation, Cipla Limited, Amneal Pharmaceuticals, Inc., Novartis AG, and AbbVie, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User (Volume, Thousand Units, USD Billion, 2019-2030)- Homecare Settings
- Hospitals & Clinics
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Acrylic Adhesives
- Silicone Adhesives
- Hydrogel Adhesives
- Others
- Drug-In-Adhesive
- Matrix Patches
- Reservoir Membrane Patches
- Microneedle Patches
- Iontophoresis Patches
- Vapour Patches
- Pain Management
- Smoking Cessation
- Hormone Replacement Therapy
- Cardiovascular Disorder
- Central Nervous System Disorder
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
Companies Profiled- Johnson & Johnson
- Viatris, Inc. (Mylan N.V.)
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Bayer AG
- Nitto Denko Corporation
- Cipla Limited
- Amneal Pharmaceuticals, Inc.
- Novartis AG
- AbbVie, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Transdermal Patches Market by End User
Chapter 6. LAMEA Transdermal Patches Market by Distribution Channel
Chapter 7. LAMEA Transdermal Patches Market by Adhesive Type
Chapter 8. LAMEA Transdermal Patches Market by Patch Type
Chapter 9. LAMEA Transdermal Patches Market by Application
Chapter 10. LAMEA Transdermal Patches Market by Country
Chapter 11. Company Profiles
Companies Mentioned
- Johnson & Johnson
- Viatris, Inc. (Mylan N.V.)
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Bayer AG
- Nitto Denko Corporation
- Cipla Limited
- Amneal Pharmaceuticals, Inc.
- Novartis AG
- AbbVie, Inc.
Methodology
LOADING...
